What's new

Human medicines European public assessment report (EPAR): Bemrist Breezhaler, indacaterol,mometasone, Date of authorisation: 30/05/2020, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Bemrist Breezhaler, indacaterol,mometasone, Date of authorisation: 30/05/2020, Revision: 8, Status: Authorised

Mar 6, 2025 - 09:40
 0
Human medicines European public assessment report (EPAR): Bemrist Breezhaler, indacaterol,mometasone, Date of authorisation: 30/05/2020, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Bemrist Breezhaler, indacaterol,mometasone, Date of authorisation: 30/05/2020, Revision: 8, Status: Authorised
Read More

Tags:

Previous Article

Adidas confirms 500 job cuts as it lowers profit forecast

Next Article

Happy Zalando has strong 2024, expects more of the same in 2025

Related Posts

Human medicines European public assessment report (EPAR): Ultibro Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 19/09/2013, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0

Changing the labelling and package leaflet (Article 61(3) notifications)

Changing the labelling and package leaflet (Article 61(...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025  0